Rei Tan

Rei Tan currently serves as an Equity Research Associate at BTIG since March 2023, focusing on SMID Cap Biotechnology under the guidance of Senior Analyst Julian Harrison. Prior to this role, Rei worked as a Business Development Specialist at Neurocrine Biosciences from January 2021 to March 2023. Additional experience includes an Undergraduate Research Assistant position at the Peyman Golshani Lab in the David Geffen School of Medicine at UCLA from September 2019 to June 2021 and a Research Intern role with the Public Health Translational Team at the National University of Singapore, where projects involved HPV and Covid-19. Rei Tan holds a Bachelor of Science in Neuroscience and a Bachelor of Arts in the Study of Religion, both attained from UCLA between 2017 and 2021.